These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7330581

  • 41. Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.
    Kopp JB, Andress DL, Maloney NA, Sherrard DJ.
    Am J Kidney Dis; 1988 Sep; 12(3):214-9. PubMed ID: 3414677
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Bone disease in patients on maintenance haemodialysis using softened or de-ionized water.
    Hudson GA, Milne FJ, Oliver NJ, Reis P, Murray J, Meyers AM.
    S Afr Med J; 1979 Sep 08; 56(11):439-43. PubMed ID: 550366
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC, Arnala IO, Ritz E, Malluche HH.
    J Lab Clin Med; 1986 Jun 08; 107(6):481-7. PubMed ID: 3486929
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Long-term dialysis and its problems: calcium and phosphorus metabolism disorders, aluminum balance, and esteodystrophy].
    Kurokawa K.
    Nihon Rinsho; 1980 Jun 08; 38(6):2329-36. PubMed ID: 6997567
    [No Abstract] [Full Text] [Related]

  • 50. Influence of aluminium on the effect of 1 alpha (OH)D3 on renal osteodystrophy.
    Shimada H, Nakamura M, Marumo F.
    Nephron; 1983 Jun 08; 35(3):163-70. PubMed ID: 6633756
    [Abstract] [Full Text] [Related]

  • 51. Bone histoquantitative findings and histochemical staining reactions for aluminium in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminium.
    McClure J, Fazzalari NL, Fassett RG, Pugsley DJ.
    J Clin Pathol; 1983 Nov 08; 36(11):1281-7. PubMed ID: 6630577
    [Abstract] [Full Text] [Related]

  • 52. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 08; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.